Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-1990 | 12-1989 | 12-1988 | 12-1987 | |
Assets | ||||
Current Assets | ||||
Cash & Cash Equivalents | 859,126 | 489,631 | 360,784 | N/A |
Marketable Securities | 2,118,647 | 2,292,437 | 2,241,135 | N/A |
Receivables | 2,090,563 | 1,661,757 | 1,395,923 | N/A |
Inventories | 1,186,779 | 1,327,623 | 1,308,439 | N/A |
Other current assets | 387,591 | 621,408 | 305,876 | 0 |
TOTAL | $6,642,706 | $6,392,856 | $5,612,157 | $N/A |
Non-Current Assets | ||||
PPE Net | 8,695,620 | 7,678,920 | 6,981,462 | N/A |
Investments And Advances | 69,371 | 72,892 | 62,664 | 0 |
Other Non-Current Assets | 79,939 | 55,469 | 26,811 | 0 |
TOTAL | $8,844,930 | $7,807,281 | $7,070,937 | $N/A |
Total Assets | $12,509,670 | $11,660,410 | $10,622,740 | $N/A |
Liabilities | ||||
Current Liabilities | ||||
Short Term Debt | 74,355 | 108,923 | 83,258 | N/A |
Accounts payable and accrued liabilities | 654,634 | 592,363 | 508,334 | 0 |
Other current liabilities | 1,385,042 | 936,479 | 647,629 | N/A |
TOTAL | $4,171,319 | $3,647,043 | $3,192,211 | $N/A |
Non-Current Liabilities | ||||
Long Term Debt | 1,141,447 | 1,563,928 | 1,112,139 | N/A |
aiOther Non-Current Liabilities | 163,207 | 189,965 | 131,643 | 0 |
TOTAL | $1,304,654 | $1,753,893 | $1,243,782 | $N/A |
Total Liabilities | $5,475,973 | $5,400,936 | $4,426,412 | $N/A |
Shareholders' Equity | ||||
Common Shares | 632,508 | 632,508 | 509,744 | N/A |
Retained earnings | 4,840,398 | 4,057,993 | 3,977,452 | N/A |
Other shareholders' equity | 1,560,789 | 1,568,970 | 1,675,548 | 0 |
TOTAL | $7,033,695 | $6,259,471 | $6,162,744 | $N/A |
Total Liabilities And Equity | $12,509,668 | $11,660,407 | $10,589,156 | $0 |